Cheshire drug maker Alexion Pharmaceuticals Inc. has appointed Andreas Rummelt to its board of directors.
Rummelt was a member of the executive committee of Novartis from 2006 to 2010, where he most recently served as group head of quality assurance and technical operations. (AP)
